South-East Asia
Diabetes report 2000 — 2045
Estimates were made for the seven countries and territories in the IDF South-East Asia (SEA) Region. All countries except Bhutan had primary data sources, which were used to generate estimates for diabetes in adults aged 20-79 years. A total of 9 data sources from these six countries were used. All data sources that were used to generate estimates are older than five years.

IDF projects that the number of people with diabetes in SEA Region will increase 68% reaching 152 million by 2045 and the prevalence of diabetes will increase 30% reaching 11.3% in 2045. In 2021, 65.3 billion USD was spent on diabetes in SACA Region, representing 6.7% of the total spent worldwide. The proportion of undiagnosed diabetes is third highest in the SEA Region with 51.2%. The proportion of pregnancies affected by hyperglycaemia is the highest among IDF Region with 25.9%. Only 10.1 billion USD was spent on diabetes in SEA Region, representing 1% of the total spent worldwide, despite the region being home to 16.8% of people with diabetes worldwide.

Roughly 88 million adults aged 20–79 years have diabetes in the IDF South-East Asia Region. This is the second highest total of all IDF Regions and represents almost 9% of the regional population in this age group.
57% (nearly 50 million) of adults aged 20–79 years with diabetes are undiagnosed.
31 million adults aged 20–79 years have impaired glucose tolerance, 3% of the regional population in this age group.
An estimated 184,000 children and adolescents under the age of 20 are living with type 1 diabetes in the South-East Asia Region.
Over 1 million people died due to diabetes in 2019 – the second highest number of deaths of all IDF Regions.